Introduction {#s1}
============

Production efficiency in animal agriculture is critically important in order to meet the increasing needs of high quality meat protein of a growing global human population. Modern broiler chickens have been highly selected for rapid growth and feed efficiency compared to unselected (progenitor or heritage) chicken breeds. Consequently, the understanding of key regulatory mechanisms for rapid muscle growth and enhanced feed efficiency is imperative with regard to more efficient, and therefore sustainable, food animal production (Niemann et al., [@B24]).

Global gene expression studies using cDNA microarray assay (Kong et al., [@B16]; Bottje et al., [@B4]; Bottje and Kong, [@B6]), RNA sequencing (Bottje et al., [@B7]), and shotgun proteomics (Kong et al., [@B15]) have been carried out on breast muscle obtained from pedigree males (PeM) exhibiting either a high or low feed efficiency (FE) phenotype. Additionally, global transcriptomics has been conducted on breast obtained from PeM broilers (characterized by rapid growth, large muscle mass and higher feed efficiency) compared with the foundational Barred Plymouth Rock (BPR) chicken breed (exhibiting slow growth, small muscle mass and lower feed efficiency) (Kong et al., [@B14]). The BPR chicken exhibits a characteristic pattern of alternating white and black bars of feather pigmentation and was developed in the United States during the mid-nineteenth century (Dorshorst and Ashwell, [@B9]). The BPR breed was developed for dual purposes of both meat and egg production and has a much slower growth rate compared to commercial broilers (Lopez et al., [@B19]). Several global expression studies showed that production efficiency may be associated with various cellular mechanisms including mitochondrial oxidative stress, myogenic growth and differentiation, inflammatory response, protein degradation, stress responses, growth hormone signaling, cell cycle, apoptosis, and fatty acid transportation. Particularly, the association between production efficiency and mitochondrial functions on energy expenditure and oxidative phosphorylation system (OXPHOS) in chicken breast muscle has been well-documented (Bottje et al., [@B5], [@B8], [@B2]; Bottje and Carstens, [@B3]; Bottje and Kong, [@B6]).

A major function of mitochondria is in producing energy (ATP) through OXPHOS in most eukaryotic cells (Taylor and Turnbull, [@B26]). Mitochondria contain their own mitochondrial DNA (mtDNA) that exhibits characteristics that differ from nuclear DNA, including divergent genetic codes, transmission by maternal inheritance of mitochondrial type, higher rates of mutation due to proximity of mtDNA to the electron transport chain, polyploidy status, and a more compact organization (Fernandez-Silva et al., [@B10]). Similar to mammalian mitochondrial genome, chicken mtDNA harbors one control region (D-loop) and contains 37 genes encoding 2 rRNA subunits (12S and 16S rRNAs), 22 transfer RNAs (tRNAs) and 13 proteins that are all involved in OXPHOS (Zhao et al., [@B27]).

In addition to mitochondrial RNAs, mtDNA encoding small RNAs (mitosRNAs) were recently discovered in human, mouse and rainbow trout (Ro et al., [@B25]; Ma et al., [@B20]). These novel mitosRNAs are hypothesized to regulate mitochondrial gene expression and mRNA stability (Ro et al., [@B25]). While mitosRNAs have been detected in mammalian cells, these have not been characterized in avian species to our knowledge. Therefore, the present study was conducted to identify mitosRNAs in avian breast muscle and to determine if differences in abundance may occur in birds exhibiting large differences in growth and muscle development in a line of birds highly selected for growth and development (PeM broilers) and a heritage breed, BPR chickens.

Materials and methods {#s2}
=====================

Ethics statement
----------------

The present study was performed in accordance with the recommended guidelines for the care and use of laboratory animals of the National Institutes of Health. All procedures for animal care were followed by animal use protocol that were reviewed and approved by the University of Arkansas Institutional Animal Care and Use Committee (IACUC Protocol \#14012).

Breast muscle tissue and RNA extraction
---------------------------------------

Pedigree male broilers within a single genetic line and RNA extraction were described previously (Bottje et al., [@B5]; Kong et al., [@B14]). Briefly, PeM and BPR chickens (6--8 weeks old, *n* = 6 per breed) were humanely killed by cervical dislocation. Breast muscle tissue was rapidly excised and immediately flash frozen in liquid nitrogen. Total RNA was isolated from the tissue using TRIzol reagent (Invitrogen Life Technologies, Thermo-Fisher Scientific, Carlsbad, CA) according to the manufacturer\'s instructions. After initial extraction, the RNA samples were treated with DNase I (New England Biolabs Inc., Ipswich, MA) and extracted a second time with TRIzol reagent. Assessing RNA quality using an Agilent 2200 TapeStation instrument (Santa Clara, CA) revealed that all RNA samples showed \>8.0 values of RNA integrity number (RIN). These RNA samples were then used for small RNA sequencing (RNAseq) analysis outlined below.

RNAseq and data analysis
------------------------

Small RNAseq library preparation for individual samples with barcoding and Illumina sequencing was carried out at the Research Technology Support Facility (Michigan State University, East Lansing, MI). The Illumina HiSeq system at this facility used a 1 × 50 bp single end read technology for sequencing the RNA samples. The RNA sequence FASTQ files that were obtained were mapped to the chicken mitochondrial genome (GenBank Accession: [X52392.1](X52392.1)) using the NGen program in Lasergene software package (DNAStar, Madison, WI). The total mapped counts were transformed to log~2~ values based on the number of reads per million (RPM) in order to stabilize the variance. The resulting normalized values were then subjected to further statistical analyses using the JMP Genomics 8 (SAS Institute Inc., Cary, NC). The small RNAs aligned to mitochondrial genome showing \>100 average read counts derived by six individual samples, adjusted *p*-value (false discovery rate; FDR) \<0.05 after *t*-test and log~2~ fold change \>0.5 were considered as differentially expressed (DE) between PeM and BPR. The *p*-value correction (FDR calculation) was performed by multiple tests of Benjamini and Hochberg method ([@B1]) using JMP Genomics 8.

Nomenclature of identified mitosRNAs
------------------------------------

The mitosRNA sequences were identified based on previous reports (Ro et al., [@B25]; Ma et al., [@B20]), and their naming was simplified somewhat to contain five parts: \[species\]-mitosRNA-\[strand\]-\[location\]-\[variants/fragments\]. As an example, gga-mitosRNA-H-2344-1 refers to chicken mitochondrial small RNA derived from the 2344 locus on the heavy strand of the first fragment, whereas gga-mitosRNA-L-16707 refers to chicken mitochondrial small RNA derived from the 16707 locus on the light strand. If multiple fragments determined to have been derived from the same gene locus, the fragments were sequentially numbered.

Quantitative PCR of mitosRNA
----------------------------

Quantitative PCR (qPCR) was conducted following the method reported previously (Ro et al., [@B25]; Ma et al., [@B20]) with modifications. Briefly, 60 μg of total RNA obtained from 6 muscle samples from PeM and BPR breast muscle was used for general validation of the RNAseq results and for specific confirmation of the most abundant mitosRNAs for each mitochondrial gene region. Small RNAs were purified from total RNA samples using a miRNA isolation kit (mirVana, Thermo Fisher Scientific, Waltham, MA), polyadenylated with a *E. coli* Poly-A Polymerase (Thermo Fisher Scientific) and reverse transcribed to cDNA using an adapter primer containing poly T residues at 3′-end (Table [1](#T1){ref-type="table"}) and SuperScript III reverse transcriptase (ThermoFisher Scientific) following the manufacturer\'s instructions. The resulting cDNA samples were diluted (1:10) and a portion (2 μL) was used for qPCR determination (total volume of 25 μL) with an ABI prism 7500HT system (ThermoFisher Scientific) with PowerUp™ SYBR® Green Master Mix (ThermoFisher Scientific). Specific oligonucleotide primers for individual mitosRNA and the universal reverse primer are shown in Table [1](#T1){ref-type="table"}. The conditions of real-time qPCR amplification were as follows: 1 cycle at 95°C (10 min), 40 cycles at 95°C (15 s each), followed by 60°C for 1 min. The chicken small 5S rRNA gene was used as the internal control. All qPCR reactions were conducted in duplicate and the values of average cycle threshold (Ct) determined for each sample (*n* = 6 for each PeM and BPR). The 2^−ΔΔCt^ values were calculated using the average ΔCt (PeM) − average ΔCt (BPR) indicating that the BPR group values were set to 1 and used for relative quantification by linear fold-change. The statistical significance (*p* \< 0.05) between PeM and BPR values were determined by *t*-test.

###### 

Primers used for qPCR.

  -----------------------------------------------------------------------
  **Primer name**             **Primer sequence**
  --------------------------- -------------------------------------------
  gga_mitosRNA_H\_1781_F      ACATGTATCCGCCTGAGAACT

  gga_mitosRNA_H\_2346_6\_F   TCTAGCCCGACAAACTCGTA

  gga_mitosRNA_H\_4040_F      ACATGACCCTGCCCACCCTAA

  gga_mitosRNA_H\_4957_F      ATGCCTCTGACATACCAGCAT

  gga_mitosRNA_H\_8083_F      AAGTACTCCAACCCGAATTA

  gga_mitosRNA_H\_8272_F      ACCAATTACATAGACCTGTC

  gga_mitosRNA_H\_8487_F      AGATGCCCAAGAAGTTGAAC

  gga_mitosRNA_H\_9163_F      TCACTCTAACAAACAACCCT

  gga_mitosRNA_H\_10617_F     TCGGATTTGAAGCAGCAGCCT

  gga_mitosRNA_H\_11350_F     ACCCCATCATTCGCCCTTGT

  gga_mitosRNA_H\_11664_F     TCAACTCCCCTCTTAGTACT

  gga_mitosRNA_H\_15821_F     AACGAACAATAACCTTCCGA

  5S_rRNA-F1                  AAGCCTACAGCACCCGGTAT

  RTQ-UNI_R                   CGAATTCTAGAGCTCGAGGCAGG

  RT-Primer with adapter      CGAATTCTAGAGCTCGAGGCAGGCGACATGG\
                              CTGGCTAGTTAAGCTTGGTACCGAGCTCG\
                              GATCCACTAGTCCT TTTTTTTTTTTTTTTTTTTTTTTTVN

  ND1_F                       ACCCTAGCCATCATCCTGTT

  ND1_R                       TCCTGAGACTAGCTCTGACT

  ND2_F                       AGCATAACCAACGCCTGATC

  ND2_R                       GATGTTAGGAGGAGGAGTGT

  COX1_F                      TCCTTCTCCTACTAGCCTCA

  COX1_R                      AGGAGTAGTAGGATGGCAGT

  COX2_F                      AGGCTTTCAAGACGCCTCAT

  COX2_R                      GTGAGATCAGGTTCGTCGAT

  ATP8_F                      ATGCCCCAATTAAACCCTTTCCCA

  ATP8_R                      TTAGGTTCATGGTCAGGTTCA

  ATP6_F                      AATTCTCAAGCCCCTGCCTA

  ATP6_R                      AGGAGGCCTAGGAGGTTAAT

  COX3_F                      TAGTTGACCCAAGCCCATGA

  COX3_R                      GTAGGCCCTTTTGGACAGTT

  ND3_F                       TCTACTAAGCGCTGCACTAA

  ND3_R                       AGGGCGATTTCTAGGTCGAA

  ND4L_F                      TCCCCTACACTTCAGCTTCT

  ND4L_R                      TTCGCATGCTGAGAAGGCTA

  ND4_F                       TCGATCAGCCTACACTGACT

  ND4_R                       TGGGATTAGGGTTGCTTCGA

  ND5_F                       AGCCTCAATGGAGAACAAGACA

  ND5_R                       TGTGGCAAGTAGTGTAAGTGA

  CYTB_F                      TGCCTCATGACCCAAATCCT

  CYTB_R                      AGTGTGAGGAGGAGGATTACT

  ND6_F                       AGACAACCCACGCACAAGCT

  ND6_R                       CTAGGTTTTGTCTTGGTGGT

  GAPDH_F                     ACAGCAACCGTGTTGTGGAC

  GAPDH_R                     CAACAAAGGGTCCTGCTTCC
  -----------------------------------------------------------------------

*The first column indicates primer names and the second column shows sequences for the forward and reverse primers*.

Determination of mitochondrial contents using qPCR
--------------------------------------------------

Total DNAs of muscle samples were purified using Zymo Tissue and Insect DNA mini Prep kit (Zymo Research, Irvine, CA). Ten nanogram of total DNA were subjected to qPCR reaction with primers for mitochondrial genes that included; (a) NADH-ubiquinone oxidoreductase chain (ND): ND1, ND2, ND3, ND4, ND5, ND6, (b) cytochrome oxidase (COX): COX1, COX2, COX3, (c) cytochrome b (CYTB), and (d) ATPase (ATP) 6, and ATP8, as well as nuclear encoded genes (glyceraldehyde-3-phosphate dehydrogenase; GAPDH) using an ABI prism 7500HT system (ThermoFisher Scientific) with PowerUp™ SYBR® Green Master Mix (ThermoFisher Scientific). The specific oligonucleotide primers are listed in Table [1](#T1){ref-type="table"} and quantifying methods described above.

Results and discussion {#s3}
======================

Identification of breast muscle MitosRNAs in chicken
----------------------------------------------------

Twelve small RNAseq libraries were constructed using RNA isolated from breast muscles obtained from PeM and BPR chickens (*n* = 6 per group) and sequenced with the 1 × 50 bp single end read method. A total of \~41 million 50 bp sequence reads were produced with an average of \~3.3 million reads per sample (data not shown). After quality assessment, adapter trimming of raw reads, and alignment to chicken mitochondrial genome (GenBank Accession: [X52392.1](X52392.1)) using the NGen program, \~1.4 million reads with an average of \~120,000 reads per sample (\~350 × average coverage) were aligned to the entire sequence of the mitochondrial genome (data not shown). About 97% of reads used in alignment were in the sense orientation of the mitochondrial genome (data not shown). Totally 183,416 unique small RNA sequences were identified as potential chicken mitochondrial genome encoding small RNAs (mitosRNAs) (data not shown). After stringent filtering, 117 mitosRNAs showing \>100 raw read counts were abundantly produced from all 37 mitochondrial genes (except D-loop region), all of them were in sense orientation, and the length of mitosRNAs ranged from 22 to 46 nucleotides (Supplementary Table [1](#SM1){ref-type="supplementary-material"}).

Only four mitosRNAs (gga_mitosRNA_L\_6542, gga_mitosRNA_L\_16177, gga_mitosRNA_L\_16707, and gga_mitosRNA_L\_16745) were derived from the light strand while 113 mitosRNAs were derived from heavy strand mitochondrial DNA (Supplementary Table [1](#SM1){ref-type="supplementary-material"}). Similar to findings by Ma et al. ([@B20]), the mitosRNAs were not evenly distributed across the mitochondrial genome (Figure [1](#F1){ref-type="fig"}). Within the D-loop, rRNA, tRNA, and protein coding regions, the protein- and rRNA coding regions produced much higher number of mitosRNAs (Figure [2](#F2){ref-type="fig"}), which differs from reports in other species that showed higher mitosRNA frequencies in tRNA coding regions (Lee et al., [@B18]; Mercer et al., [@B21]; Kumar et al., [@B17]; Goodarzi et al., [@B11]; Hirose et al., [@B12]; Ma et al., [@B20]). The unique condition of higher mitosRNAs in mitochondrial protein- and rRNA genes suggests that mitochondrial functions of electron transport chain associated with energy expenditure and OXPHOS in avian muscle may be regulated by unique mechanisms different from other species. Interestingly, our earlier results of global gene expression, in which same RNA samples were used, indicated that muscle growth and fiber composition may be regulated by distinct mitochondrial functions in chicken that might be different from other species (Kong et al., [@B14]).

![Distribution of mitosRNA in the chicken mtDNA regions. Red histograms indicate abundance level of mitosRNAs. Relative location of genes were derived from NCBI genome viewer. Bars of red, purple, and black indicate regions of protein coding, transfer/ ribosomal RNA coding, and regulatory D-loop, respectively.](fphys-08-00816-g0001){#F1}

![Relative expression of total mitosRNAs in each mitochondrial gene. X axis indicates mitochondrial coding regions, while Y axis represents depth of coverage (raw sequence read counts as results of small RNA sequencing).](fphys-08-00816-g0002){#F2}

Differentially expressed (DE) mitosRNA in PeM compared to BPR
-------------------------------------------------------------

Since our previous global gene expression study (Kong et al., [@B14]) indicated differential functions of mitochondria in muscles between PeM (rapid growth and large muscle mass) and foundational BPR chickens (slow growth and small muscle mass), differentially expressed (DE) mitosRNA between PeM and BPR were analyzed in the present study. Of the 117 potential mitosRNAs, 44 DE mitosRNAs with adjusted *p*-values (FDRs) \<0.05 were identified. All of the DE mitosRNAs were upregulated in PeM breast, except those that were encoded by the 16S-rRNA gene region (Table [2](#T2){ref-type="table"}). Similar to the abundance of total mitosRNAs, only 3 mitosRNAs (gga_mitosRNA_H\_4040, gga_mitosRNA_H\_8272, and gga_mitosRNA_H\_8277) were derived from tRNA coding region while 41 mitosRNAs were derived from mitochondrial protein- and rRNA coding regions (Table [2](#T2){ref-type="table"}). The mitosRNAs may be expected to regulate expression and stability of mRNA that is the origin of the designated mitosRNA (Ro et al., [@B25]; Ma et al., [@B20]). To validate small RNAseq results, a subset of 12 mitosRNAs that were the most abundant in each gene were subjected to qPCR (Table [3](#T3){ref-type="table"}). Results indicated that expression levels for 11 of 12 mitosRNAs were well-matched between small RNAseq and qPCR analyses in terms of the direction and magnitude of change (Table [3](#T3){ref-type="table"}). One possible reason why the DE value of a mitosRNA was not matched between RNAseq and qPCR may be related to the use of different normalization approaches between the two methods. The mitosRNAs showing similar DE predictions can be considered the most important of our reported data.

###### 

The differentially expressed mitosRNAs in PeM (*N* = 6) compared to BPR (*N* = 6).

  **Name**                  **RNA sequence**                                 **Length**   **Region**   **A[^\*^](#TN1){ref-type="table-fn"}**   **M[^\*\*^](#TN2){ref-type="table-fn"}**   **FDR**
  ------------------------- ------------------------------------------------ ------------ ------------ ---------------------------------------- ------------------------------------------ ---------
  gga_mitosRNA_H\_1426      GTAGCCCAAGACGCCTTGCTTAAGCC                       26           12S rRNA     10.17                                    1.79                                       0.0376
  gga_mitosRNA_H\_1781      ATCACACATGTATCCGCCTGAGAACTACGAGCACA              35           12S rRNA     13.33                                    1.66                                       0.0395
  gga_mitosRNA_H\_1816      AACGCTTAAAACTCTAAGGACTTGGCGGTGCCCCA              35           12S rRNA     9.98                                     2.23                                       0.0143
  gga_mitosRNA_H\_2346_1    CTTGCCCCCCCTCTAGCCCGACAAACTAGTA                  31           16S rRNA     10.72                                    −1.47                                      0.0165
  gga_mitosRNA_H\_2346_2    CTTGCCCCCCCTCTAGCCCGACAAACTCATAC                 32           16S rRNA     10.11                                    −1.50                                      0.0218
  gga_mitosRNA_H\_2346_3    CTTGCCCCCCCTCTAGCCCGACAAACTCCTAC                 32           16S rRNA     12.02                                    −1.46                                      0.0451
  gga_mitosRNA_H\_2346_4    CTTGCCCCCCCTCTAGCCCGACAAACTCGCACC                33           16S rRNA     11.59                                    −1.44                                      0.0218
  gga_mitosRNA_H\_2346_6    CTTGCCCCCCCTCTAGCCCGACAAACTCGTACCCTTAACATAAAAA   46           16S rRNA     17.95                                    −1.19                                      0.0387
  gga_mitosRNA_H\_2346_8    CTTGCCCCCCCTCTAGCCCGACAAACTCGTCCC                33           16S rRNA     12.23                                    −1.62                                      0.0285
  gga_mitosRNA_H\_2346_10   CTTGCCCCCCCTCTAGCCCGACAAACTGGTA                  31           16S rRNA     10.49                                    −1.54                                      0.0165
  gga_mitosRNA_H\_2346_11   CTTGCCCCCCCTCTAGCCCGACAAACTTGTA                  31           16S rRNA     11.21                                    −1.91                                      0.0156
  gga_mitosRNA_H\_3067      TTATTAACAGAACTCAACTTATACCCCCA                    29           16S rRNA     11.48                                    2.36                                       0.0080
  gga_mitosRNA_H\_3421      ATAAGACGAGAAGACCCTGTGGAACTTTAA                   30           16S rRNA     11.55                                    1.75                                       0.0218
  gga_mitosRNA_H\_4040      TACCCCGGACATGACCCTGCCCACCCTAACA                  31           tRNA-Leu     13.55                                    1.16                                       0.0156
  gga_mitosRNA_H\_4554      TTAAGCACCCTGGCCATCACCCAAGAACCC                   30           ND1          11.53                                    3.91                                       0.0156
  gga_mitosRNA_H\_4957      TAACCCTAGCCTTATGCCTCTGACATACCAGCATACC            37           ND1          11.59                                    2.39                                       0.0092
  gga_mitosRNA_H\_5727      CTAATCGGAGGCTGAATGGGCCTAAACC                     28           ND2          11.33                                    2.20                                       0.0218
  gga_mitosRNA_H\_5954      AATACTAAATGCAACTGTAATACTAACCC                    29           ND2          11.27                                    2.82                                       0.0048
  gga_mitosRNA_H\_6276_1    CTACAGAAACTTAGGATTAACTGTCACC                     28           ND2          13.71                                    1.62                                       0.0156
  gga_mitosRNA_H\_6678      AACCACAAAGACATTGGCACTCTTTACCT                    29           COX1         10.37                                    2.84                                       0.0048
  gga_mitosRNA_H\_7156      TAAAACCCCCCGCACTGTCACAATACC                      27           COX1         11.30                                    1.63                                       0.0048
  gga_mitosRNA_H\_8083      GAAAAGTACTCCAACCCGAATTAACT                       26           COX1         11.86                                    1.76                                       0.0156
  gga_mitosRNA_H\_8272      AAACCAATTACATAGACCTGTCAAGACTA                    29           tRNA-Asp     12.71                                    1.66                                       0.0349
  gga_mitosRNA_H\_8277      AATTACATAGACCTGTCAAGACTAA                        25           tRNA-Asp     11.47                                    1.76                                       0.0080
  gga_mitosRNA_H\_8375      CATCATAGAAGAGCTCGTTGAATTCCAC                     28           COX2         10.30                                    2.60                                       0.0218
  gga_mitosRNA_H\_8487      AACACCGTAGATGCCCAAGAAGTTGAACTAATCTGAACC          39           COX2         12.41                                    2.25                                       0.0221
  gga_mitosRNA_H\_9163      AAACTTCTTTCATTCACTCTAACAAACAACCCTGCA             36           ATP8         12.92                                    1.65                                       0.0080
  gga_mitosRNA_H\_9235      TGACCATGAACCTAAGCTTCTTCGACC                      27           ATP8         8.31                                     2.04                                       0.0354
  gga_mitosRNA_H\_9601      AACCCTCCGCCTCCTTAGGACACCTACTCCCTGAAGGCACCCC      43           ATP6         12.18                                    2.04                                       0.0266
  gga_mitosRNA_H\_9757      AACTTATCTCTACAGCCACAATCGCCCTACTACC               34           ATP6         13.36                                    1.44                                       0.0080
  gga_mitosRNA_H\_9800      ATCAATCTCCGCCCTAACGGCACTCA                       26           ATP6         10.67                                    2.89                                       0.0080
  gga_mitosRNA_H\_9871      AAGCCTACGTCTTCGTCCTCCTCCTAAGCCTCTACTTACA         40           ATP6         12.85                                    1.50                                       0.0156
  gga_mitosRNA_H\_10617     ACTTCGGATTTGAAGCAGCAGCCTGATACTG                  31           COX3         10.57                                    2.68                                       0.0218
  gga_mitosRNA_H\_11350     AAACCCCATCATTCGCCCTTGTACC                        25           ND4_L        9.38                                     2.03                                       0.0218
  gga_mitosRNA_H\_11633     AAAACCCTAACCCTCTGAACAGGCATAGACCA                 32           ND4          11.42                                    2.36                                       0.0049
  gga_mitosRNA_H\_11664     AAATCTCAACTCCCCTCTTAGTACTCTCCTGC                 32           ND4          12.93                                    2.05                                       0.0049
  gga_mitosRNA_H\_11665     AATCTCCACTCCCCTCTTAGTACTCTCCTGC                  31           ND4          10.70                                    2.65                                       0.0005
  gga_mitosRNA_H\_11905     AGAACGACTTAGCGCAGGCATTTACC                       26           ND4          9.48                                     1.55                                       0.0218
  gga_mitosRNA_H\_12707     CTCTACATACTACTCTCAACCCAACGAGGCACTC               34           ND4          10.09                                    1.56                                       0.0218
  gga_mitosRNA_H\_12766     CAACTCAAACACTCGAGAACATCTTCTCATAACCC              35           ND4          10.11                                    2.41                                       0.0218
  gga_mitosRNA_H\_12824     CTCATCCTCAAACCAGAACTAATCTCAGGAACCC               34           ND4          11.78                                    2.58                                       0.0080
  gga_mitosRNA_H\_15821     AATCTAAACAACGAACAATAACCTTCCGACC                  31           CYTB         12.75                                    1.98                                       0.0048
  gga_mitosRNA_H\_15860     AAACCCTATTCTGACTTCTAGTAGCCAACC                   30           CYTB         11.93                                    1.87                                       0.0218
  gga_mitosRNA_H\_15904     TGAATCGGAAGCCAACCAGTAGAACACCCC                   30           CYTB         9.53                                     3.17                                       0.0218

*A denotes Log2 value of average expressions*.

*M means Log2 fold change of differential expressions*.

###### 

Comparison of fold changes (FC) between RNAseq and qPCR.

  **Gene symbol**          **PeM (*****N*** = **6) vs. BPR(*****N*** = **6)**                                
  ------------------------ ---------------------------------------------------- -------- ------- ----------- -----------
  gga_mitosRNA_H\_1781     3.17                                                 0.0395   5.67    0.0007850   12 S rRNA
  gga_mitosRNA_H\_2346_6   −2.28                                                0.0387   −1.36   0.0476534   16 S rRNA
  gga_mitosRNA_H\_4040     2.23                                                 0.0156   2.02    0.0007420   tRNA-Leu
  gga_mitosRNA_H\_4957     5.23                                                 0.0092   3.55    0.0000156   ND1
  gga_mitosRNA_H\_8083     3.40                                                 0.0156   3.24    0.0014579   COX1
  gga_mitosRNA_H\_8272     3.17                                                 0.0349   −2.40   0.0255489   tRNA-Asp
  gga_mitosRNA_H\_8487     4.77                                                 0.0221   4.22    0.0001418   COX2
  gga_mitosRNA_H\_9163     3.14                                                 0.0080   3.03    0.0000015   ATP8
  gga_mitosRNA_H\_10617    6.41                                                 0.0218   2.48    0.0007107   COX3
  gga_mitosRNA_H\_11350    4.09                                                 0.0218   4.39    0.0000091   ND4_L
  gga_mitosRNA_H\_11664    4.13                                                 0.0049   4.62    0.0000016   ND4
  gga_mitosRNA_H\_15821    3.94                                                 0.0048   5.81    0.0000010   CYTB

*Values denote linear fold changes*.

Comparison between DE MitosRNA and DE mRNA
------------------------------------------

In order to determine the abundance of total mitosRNAs encoded by each mitochondrial gene, the read counts of all mitosRNAs in a gene region were added to represent a gene and then compared between PeM and BPR. In these results, we noted the same differential pattern as that shown in the DE individual mitosRNA (data not shown). Since DE mitosRNAs were mostly found in protein coding genes (mRNA), the DE mitosRNAs were compared to gene expression derived from the RNAseq analysis conducted on the same muscle samples (Kong et al., [@B14]). In the RNAseq analysis conducted in the previous study (Kong et al., [@B14]), differential expression of mitochondrial mRNA was not observed between PeM and BPR (Table [4](#T4){ref-type="table"}). However, when data from both DE mitosRNAs and non-DE mitochondrial mRNA were considered, distinct phenotypes (rapid growth, greater muscle mass, fiber composition change) associated with mitochondrial functions shown in modern PeM may be regulated by higher mitosRNA production than the mitochondrial mRNAs (Table [4](#T4){ref-type="table"}). Thus, potential regulatory activities of mitosRNAs may influence the stability of the source mRNA and, in turn, ultimately affect the protein abundance and protein functionalities in electron transport chain for OXPHOS and energy expenditure. Future studies on mitosRNAs in chicken muscles will be important to characterize the regulation of differential mitochondrial protein abundance and their functions influenced by mitosRNAs.

###### 

Comparison of differential expression of mitosRNA and mRNA in gene regions of mitochondrial genome in PeM breast muscle (*N* = 6) compared to BPR (*N* = 6).

  **Gene Region**   **mitosRNA**   **mRNA**           
  ----------------- -------------- ---------- ------- ----------
  ATP6              1.33           0.00013    0.26    0.195682
  CYTB              1.54           0.0003     0.31    0.129304
  ND2               1.51           0.00032    0.36    0.198144
  ND4               1.30           0.00054    0.05    0.753202
  ND1               1.34           0.00116    −0.02   0.928934
  ATP8              1.09           0.00134    0.58    0.078447
  ND5               0.94           0.00442    0.14    0.306487
  COX1              1.09           0.00481    0.09    0.68997
  COX3              0.83           0.00697    −0.07   0.800796
  ND4L              1.09           0.00889    0.01    0.978282
  COX2              1.02           0.01297    na      na
  ND3               0.90           0.05364    0.17    0.552786
  ND6               −0.11          0.5783     0.83    0.003621

Differential abundance of mitosRNAs correlated with mitochondrial contents
--------------------------------------------------------------------------

While higher abundance of mitosRNAs in PeM could be a function or result from higher mitochondrial content in the muscle tissue, a global transcriptomic study conducted on the same tissue samples reported a significant skew of the mitochondrial proteome in the BPR muscle compared to the PeM which suggests that the mitochondrial content was greater in the BPR tissue than in the PeM tissue (Kong et al., [@B14]). This finding conflicts with the results of the present study. For this reason, mitochondrial contents were determined by qPCR with muscle DNA and primers for various gene regions (e.g., ND1, ND2, ND3, ATP6, ATP8, COX2, COX3 etc.) of mitochondrial genome, compared with stationary contents of nuclear DNA sequences (GAPDH). When the same amount of DNA was used, the average contents of nuclear genes were very similar among samples in a group and even between groups of PeM and BPR (data not shown), suggesting nuclear DNA copy numbers are the same between samples. In contrast, the average content of mitochondrial genes are slightly higher in PeM compared to BPR (Figure [3](#F3){ref-type="fig"}). Mitochondrial DNA sequences were \~1.58-fold higher in average throughout the mitochondrial genes in PeM samples compared to BPR muscles, indicating a modest increase of mitochondrial content in modern breeds selected for growth and FE (Figure [3](#F3){ref-type="fig"}). This result supports the argument that the higher abundance of mitosRNAs in PeM muscles may be derived from the higher mitochondrial contents. Further studies are warranted to fully characterize functions of the lower abundance of mitosRNAs derived from 16S ribosomal RNA in PeM.

![Differential mitochondrial contents. X axis indicates mitochondrial protein coding regions, while Y axis represents ratio of DNA contents calculated by DNA contents of PeM divided by DNA contents of BPR. Data are the mean ± S.E. from six individual samples per group.](fphys-08-00816-g0003){#F3}

According to an earlier transcriptomic investigation with the same tissue samples (Kong et al., [@B14]), upregulated muscle-related genes suggested a possible higher slow muscle fiber composition in PeM compared to BPR. In addition, an independent report by Mutryn et al. ([@B23]) suggested that wooden breast myopathy (which in commercial broilers showed a dramatic upregulation of troponin I1, myoglobin, myosin binding protein C1, and myozenin 2 genes compared to unaffected muscle) may undergo fast-to-slow fiber type switching. Slow-twitch or oxidative fibers usually possess a higher mitochondrial content, slower contraction rates, increased reliance on OXPHOS, higher fatigue resistance, and higher representation of postural muscles. In contrast, fast-twitch or glycolytic fibers have lower mitochondrial content, rapid contractions, decreased reliance on OXPHOS, low resistance to fatigue, and high representation in muscle groups used for directional movement (Mishra et al., [@B22]). Chickens have white breast muscle composed primarily of fast twitch glycolytic fibers bearing low mitochondrial content (e.g., Kiessling, [@B13]). Thus, the fact that higher mitosRNAs with higher mitochondrial contents retained in PeM breast may be indicative evidence for fiber type switching to increase slow-twitch fibers in modern broiler breasts.

In mammals, mitosRNAs are known to be generated by unidentified ribonucleases retained in mitochondria since mammalian mitosRNAs contain 5′ phosphate and 3′ hydroxyl termini that are found in microRNA and small nucleolar RNAs (snoRNAs) (Ro et al., [@B25]). Depending on the orientation, sense mitosRNAs enhance the expression of host mitochondrial genes by targeting anti-sense transcripts. In contrast, anti-sense mitosRNAs inhibit mitochondrial gene expression by targeting sense transcripts (Ro et al., [@B25]). Chicken muscle mitosRNAs, which were significantly expressed in this study, are all sense orientations: suggesting that the mitosRNAs may enhance the expression of mitochondrial genes by suppressing antisense RNAs in modern PeM broilers compared to unselected BPR. Although the mRNA expression of mitochondrial genes were not different between PeM and BPR, mRNA stability may be influenced by mitosRNA and, in turn protein production may be affected. Thus, further studies on mitochondrial protein encoding and synthetic machinery may need to be conducted in the future in order to fully understand the role that mitosRNA plays in growth and development of muscle in modern broilers.
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